Home FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug
 

Keywords :   


FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug

2014-06-08 05:12:05| Biotech - Topix.net

The FDA has removed its clinical hold on patient enrollment and dosing of PEGPH20 in an ongoing phase II trial evaluating the investigational compound in patients with pancreatic cancer, permitting the study to resume under a revised protocol.

Tags: study hold drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »